Not medical advice. Talk to your provider before using any peptide.
Full disclaimerPeptide Schedule Research TeamReviewed Apr 20265 Citations
CJC-1295 DAC extends growth hormone signaling for days per injection, not hours. A Phase I trial (n=65) confirmed IGF-1 elevation lasting 9 to 11 days. Once-weekly dosing convenience comes with persistent water retention and a discontinued Phase II trial.
1mg · Weekly
Summary: Add 2mL BAC water to your 2mg vial. Draw to 100.0 units on a U-100 syringe for a 1mg dose. This vial will last 2 doses.
View side effects and safety warnings →
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 1mg | Weekly |
| Moderate | 2mg | Weekly |
| Aggressive | 2mg | 2x/week |
Reconstitution math for common vial sizes. A 5 mg vial with 2 mL bacteriostatic water gives you 2,500 mcg per mL. For a 1,000 mcg dose, pull 40 units on a standard U-100 insulin syringe. For 2,000 mcg, pull 80 units. A 2 mg vial with 1 mL BAC water gives 2,000 mcg per mL; a 1,000 mcg dose is 50 units. Timing matters less with DAC than with the no-DAC form. You don't need to fast before injection. Evening dosing before bed is preferred because it complements natural nocturnal GH secretion, but the sustained release means missing that window by a few hours changes nothing meaningful. The thing most beginners miss is vendor verification. DAC synthesis requires maleimido-group bioconjugation chemistry that is far more complex than standard peptide production. Community mass spec testing has documented cases of no-DAC product sold as DAC. Request LC-MS/MS certificates of analysis; DAC molecular weight runs roughly 5.9 kDa versus 3.4 kDa for no-DAC. If your weekly injection doesn't hold IGF-1 raised for seven to nine days (testable with a mid-week blood draw), you may have the wrong compound.
Dosing based on Community dosing consensus from peptide research communities — 8 published references.View all sources →
Cross-check your CJC-1295 (DAC) reconstitution math with AI
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
CJC-1295 DAC extends growth hormone signaling for days per injection, not hours. A Phase I trial (n=65) confirmed IGF-1 elevation lasting 9 to 11 days. Once-weekly dosing convenience comes with persistent water retention and a discontinued Phase II trial.